Kaadan, Mohamad – Trademark Portfolio

Entity Type: 01

Kaadan, Mohamad holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 8 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include SUPREME OVAMAX, SUPREME MOTILITY MAX, and SUPREME SPERMCOUNT MAX. The owner is based in Redmond, WA.

14572 NE 95th St.

Redmond, WA 98052

9 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Kaadan, Mohamad's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (8 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

Frequently Asked Questions

How many trademarks does Kaadan, Mohamad have?

Kaadan, Mohamad has 9 U.S. trademarks filed with the USPTO. Of these, 3 registered, 6 abandoned.

What trademark classes does Kaadan, Mohamad file in?

Kaadan, Mohamad files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Kaadan, Mohamad's most well-known trademarks?

Kaadan, Mohamad's registered trademark portfolio includes well-known marks such as SUPREME OVAMAX, SUPREME MOTILITY MAX, and SUPREME SPERMCOUNT MAX. These are among 3 currently registered trademarks in the portfolio.

What is Kaadan, Mohamad's trademark registration success rate?

Kaadan, Mohamad has a 33% trademark registration rate, with 3 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.